IntraMed - Artículos - Status Epiléptico Convulsivo Generalizado (Parte I)
Una patología con alta morbimortalidad | 30 AGO 06
Status Epiléptico Convulsivo Generalizado (Parte I)
IntraMed inicia la publicación de artículos destacados de la Revista Argentina de Emergencias. Autores del más alto nivel internacional abordan temas de la mayor trascendencia.
(1)
Autor: Andy Jagoda Fuente: Revista Argentina de Emergencias 
Referencias Bibliograficas

1. DeLorenzo RJ, Hauser WA, Towne AR, et al.  A prospective, population based epidemiologic study of status epilepticus in Richmond, Virginia.  Neurology 1996;46:1029-35
2 Leppik IE, Derivan AT, Homan RW, et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-4.
3 Alldredge BK, Gelb AM, Isaacs M ea: A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus.  N Engl J Med 2001;345:631-637.
4 Lawn ND, Eijdicks EFM, Status Epilepticus: A critical review of management options. Can J Neurol Sci 2002;29:206-15.
5 Working Group on Status Epilepticus: Treatment of convulsive status epilepticus: Recommendations of the Epilepsy Foundations of America’s Working Group on Status Epilepticus. JAMA 1993;270:854-9.
6 Lowenstein DH, Bleck, T, Macdonald RL.  It’s time to revise the definition of status epilepticus.  Epilepsia,  1999; 40:120-122
7 Treiman DM, Meyers PD, Walton NY, et al. for the Veterans Affairs Status Epilepticus Cooperative Study Group.  A comparison of four treatments for generalized convulsive status epilepticus. NEJM 1998;339:792-8.
8 Coeytauz A, Jallon P, Galobardes B, et al.  Incidence of status epilepticus in French-speaking Switzerland (EPISTAR). Neurology 2000;55:693-7.
9 Knake S, Rosenow, F, Vescovi M, et al. Incidence if Status Epilepticus in Adults in Germany: A Prospective, Population-Based Study, Epilepsia 2001;42:714-8.
10 Vignatelli L, Caterina T, D’Alessandro R, Incidence and Short-term Prognosis of Status Epilepticus in Adults in Bologna, Italy,  Epilepsia 2003;44:964-68.
11 Logroscino G, Hesdorffer DC, Cascino GD, et al.  Long-term mortality after a first episode of status epilepticus. Neurology, 2002;58:537-41.
12 Lowenstein DH, Aldredge BK, Status Epilepticus, New Engl J Med 1998;338:970-6.
13 Jagoda A, Riggio S, Refractory status epilepticus in adults.  Ann Emerg Med, 1993;22:1337-48.
14 Walton NY, Treiman DM. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exo Neurol 7998;101:267-75.
15 Lowenstein DH, Aldredge BK. Status epilepticus in an urban hospital in the 1980s. Neurology 1993;43:483-8.
16 Meldrum B, Vigouroux R, Brierley J. Systemic factors and epileptic brain damage. Arch Neurol 1973; 29:82-87
17 The Collaborative Eclampsia Trial Group.  Which anticonvulsant for women with ecplampsia?  Evidence from the Collaborative Eclampsia Trial, Lancet, 1995; 345:1455-1463.
18 Aminoff M, Simon R. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med 1980; 69:657-666.
19 Quigg M, Shneker B, Domer P.  Current practice in administration and clinical criteria of emergent EEG.  J Clin Neurophysiol, 2001;18:162-5.
20 Delorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998;39:833-40.
21 Alldredge BK, Gelb AM, Isaacs M ea: A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus.  N Engl J Med 2001;345:631-637.
22 Appleton RE, Sweeney A, Choonara I, Robson J, Molyneux E.  Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus.   Develpmental Medicine and Child Neurology 1995;37
23 Chamberlain JM, Altieri MA, Futterman C et al.. A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care 1997;13:92-4.
24 Towne AR, DeLorenzo RJ.  Use of intramuscular midazolam for status epilepticus. J Emerg Med. 1999;17:323-8.
25 Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet 2003;42:33-58.
26 Browne T. The pharmacokinetics of agents used to treat status epilepticus. Neurology 1990;40:28-32.
27 Manno EM, New management strategies in the treatment of status epilepticus, Mayo Clin Proc. 2003;78:508-18.
28 Kilarski DJ, Buchanan C, Von Behren L. Soft-tissue damage associated with intravenous phenytoin.  N Engl J Med 1984;3111:1186-7.
29 O’Brien TJ, Cascino GD, So EL, Hanna DR.  Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin therapy.  Neurology 1998;51:1034-9.
30 Burneo JG, Anandan JV, Brakley GL.  A prospective study of the incidence of the purple glove syndrome.  Epilepsia 2001;42:1156-9.
31 Rosenow F, Arzimanoglou A, et al.  R2.ecent developments in treatment of status epilepticus: A review.  Epileptic Disorders 2002;4(2 Suppl 2): S41-S51.
32 Browne TR, Kugler AR, Eldon MA.  Pharmacology and pharmacokinetics of fosphenytoin.  Neurology 1996;46(6 Suppl 1):S3-S7.
33 Devinsky O, Leppik I, Willmore LJ, et al.  Safety of intravenous valproate.   Ann Neurol. 1995;38:670-4.
34 Giroud M, Gras D, Escousse A, Dumas R, Venaud G. Use of injectable valproic acid in status epilepticus.  Drug Investigation 1993;5:154-159.
35 Hovinga CA, Chicella MF, Rose DF, Eades SK, Dalton JT, Phelps SJ. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus.  Ann Pharmacother. 1999;33:579-584
36 Venkataraman V, Wheless JW.  Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 1999;35:147-153.
37Giroud M, Grass D, Ecousse A, et al. Use of injectable valproic acid in status epilepticus: a pilot study.   Drug Invest 1993;5:154-9.
38 Shaner DM, McCurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin, Neurology 1988;38:202-7.
39 Treiman DM, Meyers PD, Walton NY, et al. for the Veterans Affairs Status Epilepticus Cooperative Study Group.  A comparison of four treatments for generalized convulsive status epilepticus. NEJM 1998;339:792-8.
40 Walker L, Slovis C. Lidocaine in the treatment of status epilepticus. Acad Emerg Med 1997; 4:918-922
41 Pascual J, Sedano M, Polo J. Intravenous lidocaine for status epilepticus. Epilepsia 1988; 29:584-589.
42 Lampl Y, Eshel Y, Gilad R, et al. Chloral hydrate in intractable status epilepticus. Ann Emerg Med 1990; 19:674-676.
43 Yeoman P, Hutchinson A, Byrne A, et al. Etomidate infusions for the control of refractory status epilepticus. Intensive Care Med 1989; 15:255-259.
44 Kumar A, Bleck TP.  Intravenous midazolam for the treatment of refractory status epilepticus.  Crit Care Med 1992;20:483-8.
45 Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.  Epilepsia 2002; 43: 146-153.
46 Praasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and midazolam in the treatment of Refractory Status Epilepticus. Epilepsia, 2001;42:380-6.
47 Brown LA, Levin GM. Role of propofol in refractory status epilepticus.  Annals of Pharmacotherapy, 1998;32:1053-59.
48 Cannon ML, Glazier SS, Bauman LA.  Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion.  J Neurosurg 2001;95:1053-56.
49 Bray RJ. Propofol infusion syndrome  in children.  Paediatr Anaesth 1998;8:491-9.
50 Makela JP, Livanainen M, Pieninkeroinen IP. Seizures associated with propofol anesthesia. Epilepsia 1993;34:832-5.
51 Parviainen I, Uusaro a, Kalviainen R, et at. High-dose thiopental in the treatment of refractory status epilepticus in the intensive care unit. Neurology, 2002;59:1249-51.
52 Manno EM, New management strategies in the treatment of status epilepticus, Mayo Clin Proc. 2003;78:508-18.

(1)

Comentarios

Usted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014